SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615774-18-002736
Filing Date
2018-04-19
Accepted
2018-04-19 16:31:00
Documents
3
Period of Report
2018-06-08
Effectiveness Date
2018-04-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A s109689_def14a.htm DEF 14A 823641
2 GRAPHIC s109689_proxy1.jpg GRAPHIC 261630
3 GRAPHIC s109689_proxy2.jpg GRAPHIC 236856
  Complete submission text file 0001615774-18-002736.txt   1511652
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 18764119
SIC: 2834 Pharmaceutical Preparations